Calcium Carbonate contains the mineral calcium carbonate and operates in over-the-counter (OTC) functions within pharmaceuticals and nutraceuticals. Classified as an active pharmaceutical Ingredient (API) under pharmaceutical actives and precursors within pharmaceuticals and nutraceuticals technologies, it’s utilized in various pharmaceutical formulations for its calcium-based properties.
Calcium Carbonate
471-34-1
AICS (Australia), DSL (Canada), ECL (Korea), EINECS (EU), ENCS (Japan), IECSC (China), NDSL (Canada), NZIoC (New Zealand), PICCS (Phillipines), TCSI (Taiwan), TSCA (USA)
British Pharmacopeia (BP), California Proposition 65, European Pharmacopeia (Ph. Eur.), FCC Compliant, FDA 29 CFR 1910.1200, FSSAI, Generally Recognized As Safe (GRAS), United States Pharmacopeia (USP)
CaCO3
Enhanced TDS
Identification & Functionality
Chemical Family :
Calcium Salts, Carbonates
Chemical Name :
Calcium Carbonate
Ingredient Name :
Calcium Carbonate
Mineral Type :
Calcium
Pharma & Nutraceuticals Functions :
OTC
Molecular formula :
CaCO₃
Technologies :
Food Ingredients, Pharmaceuticals & Nutraceuticals
Product Families :
Pharmaceuticals & Nutraceuticals —Nutraceuticals & Supplements Minerals
Food Ingredients — Nutrition & Fortification Minerals Pharmaceuticals & Nutraceuticals — Pharmaceutical Actives & Precursors Active Pharmaceutical Ingredients (APIs)
Definition :
Calcium Carbonate, dried at 200°C for 4 hours, contains calcium equivalent to not less than 98.0% and not more than 100.5% of calcium carbonate (CaCO₃).
Applications & Uses
Markets :
Food & Nutrition,
Healthcare & Pharma
Applications :
Healthcare & Pharma — Drug Delivery & Care Solutions Other Drug & Care Solutions
Food & Nutrition — Nutrition & Well Being Nutraceuticals & Supplements
Properties
Physical Form :
Powder
Appearance :
White gran. powder
| Value | Units | Test Method / Conditions | |
| Particle Size (Through 16 mesh) | 100 | % | – |
| Particle Size (Through 18 mesh) | 100 | % | – |
| Particle Size (on 60 mesh) | 59.45 | % | – |
| Particle Size (Through 200 mesh) | 6.72 | % | – |
| Tapped Density | 1 | gm/ml | – |
| Value | Units | Test Method / Conditions | |
| Heavy Metals (as Lead) | max. 5 | ppm | – |
| Lead Content | max. 0.1 | ppm | – |
| Cadmium Content | max. 0.2 | ppm | – |
| Mercury Content | max. 0.1 | ppm | – |
| Arsenic Content | max. 0.5 | ppm | – |
| Acid Insoluble (Sub.) | 0.08 | % | – |
| Sulphate Content | max. 0.20 | % | – |
| Chloride Content | max. 250 | ppm | – |
| Iron Content | max. 0.002 | – | – |
| Fluoride Content | 0.002 | % | – |
| Moisture Content | 0.48 | % | – |
| Magnesium Content | max. 1.0 | % | – |
| Assay Content (as Calcium carbonate) | 94.73 | % | – |
| Assay Content (as Calcium) | 37.93 | % | – |
| Value | Units | Test Method / Conditions | |
| Molecular Weight | 100.09 |
| Value | Units | Test Method / Conditions | |
| Total Aerobic Count | max. 10 | cfu/gm | – |
| Total Moulds & Yeast Count | max. 10 | cfu/gm | – |
| Salmonella | Absent | /10g | USP 37 <2022> |
| E-coli | Absent | /g | – |
| Pseudomonas aeruginosa | Absent | /g | – |
| Staphylococcus aureus | Absent | /g | – |
Regulatory & Compliance
Certifications & Compliance :
British Pharmacopeia (BP), alifornia Proposition 65, European Pharmacopeia (Ph. Eur.), FCC Compliant,
FDA 29 CFR 1910.1200, FSSAI, Generally Recognized As Safe (GRAS),
United States Pharmacopeia (USP)
Chemical Inventories :
AICS (Australia), DSL (Canada), ECL (Korea), EINECS (EU), ENCS (Japan), IECSC (China), NDSL (Canada), NZIoC (New Zealand), PICCS (Phillipines), TCSI (Taiwan), TSCA (USA)
FDA Disclaimer :
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
USP Reference Standards :
USP Sodium Fluoride RS
Storage & Handling
Storage Information :
Preserve in well-closed containers.
